Emre Güney

3.8k citations

43 papers · 2.3k indexed · 3 hit papers · h-index 21

Impact in

Health Informatics top 1%
- Artificial Intelligence in Healthcare and Education
Computational Theory and Mathematics top 1%
- Computational Drug Discovery Methods

Papers in ⓘ

Molecular Biology 31
- Bioinformatics and Genomic Networks 20
- Machine Learning in Bioinformatics 5
- Protein Structure and Dynamics 3
Computational Theory and Mathematics 17
- Computational Drug Discovery Methods 17

Co-authors: Baldo Oliva (18 shared papers)Jörg Menche (6 shared papers)Albert-Ĺaszló Barabási (5 shared papers)Marc Vidal (1 shared paper)Harald Schmidt (8 shared papers)Manuela G. López (3 shared papers)Ahmed Hassan (3 shared papers)Özlem Keskin (3 shared papers)
Journals: Journal of Molecular Biology (4 papers)BMC Bioinformatics (3 papers)PLoS ONE (3 papers)Scientific Reports (2 papers)Drug Discovery Today (2 papers)
Partner nations: Spain United States Netherlands

In The Last Decade

Emre Güney

42 papers receiving 2.2k citations

Hit Papers

align trajectories log scale

Sex and gender differences and biases in artificial intelligence for biomedicine and healthcare 2020 · 297 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 npj Digital Medicine
2018 Pharmacological Reviews
2016 Nature Communications

Peers

Countries citing papers authored by Emre Güney

Since Specialization

Citations

This map shows the geographic impact of Emre Güney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emre Güney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emre Güney more than expected).

Fields of papers citing papers by Emre Güney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emre Güney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emre Güney. The network helps show where Emre Güney may publish in the future.

Co-authors

The 25 scholars most cited alongside Emre Güney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Emre Güney Line = papers co-authored together Emre Güney links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach Pharmacological Reviews ·Antonio Cuadrado, Gina Manda, Ahmed Hassan, María José Alcaraz, Coral Barbas, Andreas Daiber, Pietro Ghezzi, Rafael León, Manuela G. López, Baldo Oliva, Marta Pajares, Ana I. Rojo, Natalia Robledinos-Antón, Ángela M. Valverde, Emre Güney, Harald Schmidt Hit paper breakdown →	2018	506
2	Network-based in silico drug efficacy screening Nature Communications ·Emre Güney, Jörg Menche, Marc Vidal, Albert-Ĺaszló Barabási Hit paper breakdown →	2016	385
3	Sex and gender differences and biases in artificial intelligence for biomedicine and healthcare npj Digital Medicine ·Davide Cirillo, Silvina Catuara‐Solarz, Czuee Morey, Emre Güney, Laia Subirats, Simona Mellino, Annalisa Gigante, Alfonso Valencia, María José Rementeria, Antonella Santuccione Chadha, Nikolaos Mavridis Hit paper breakdown →	2020	297
4	From single drug targets to synergistic network pharmacology in ischemic stroke Proceedings of the National Academy of Sciences ·Ana I. Casas, Ahmed Hassan, Simon J. Larsen, Vanessa Gómez‐Rangel, Mahmoud H. Elbatreek, Pamela W. M. Kleikers, Emre Güney, Javier Egea, Manuela G. López, Jan Baumbach, Harald Schmidt	2019	163
5	HotSprint: database of computational hot spots in protein interfaces Nucleic Acids Research ·Emre Güney, Nurcan Tunçbağ, Özlem Keskin, Attila Gürsoy	2007	90
6	Architectures and Functional Coverage of Protein–Protein Interfaces Journal of Molecular Biology ·Nurcan Tunçbağ, Attila Gürsoy, Emre Güney, Ruth Nussinov, Özlem Keskin	2008	87
7	Exploiting Protein-Protein Interaction Networks for Genome-Wide Disease-Gene Prioritization PLoS ONE ·Emre Güney, Baldo Oliva	2012	86
8	Tissue Specificity of Human Disease Module Scientific Reports ·Maksim Kitsak, Amitabh Sharma, Jörg Menche, Emre Güney, Susan Dina Ghiassian, Joseph Loscalzo, Albert-Ĺaszló Barabási	2016	70
9	Biana: a software framework for compiling biological interactions and analyzing networks BMC Bioinformatics ·Javier Garcı́a-Garcı́a, Emre Güney, Ramón Aragüés, Joan Planas-Iglesias, Baldo Oliva	2010	62
10	Integrating personalized gene expression profiles into predictive disease-associated gene pools npj Systems Biology and Applications ·Jörg Menche, Emre Güney, Amitabh Sharma, Patrick J. Branigan, Matthew J. Loza, Frédéric Baribaud, Radu Dobrin, Albert-Ĺaszló Barabási	2017	49
11	A diseasome cluster-based drug repurposing of soluble guanylate cyclase activators from smooth muscle relaxation to direct neuroprotection npj Systems Biology and Applications ·Friederike Langhauser, Ana I. Casas, Vu-Thao-Vi Dao, Emre Güney, Jörg Menche, Eva Geuß, Pamela W. M. Kleikers, Manuela G. López, Albert-Ĺaszló Barabási, Christoph Kleinschnitz, Harald Schmidt	2018	40
12	A Transcriptome-proteome Integrated Network Identifies Endoplasmic Reticulum thiol oxidoreductase (ERp57) as a Hub that Mediates Bone Metastasis Molecular & Cellular Proteomics ·Naiara Santana-Codina, Rafael Carretero, Rebeca Sanz‐Pamplona, Teresa Cabrera, Emre Güney, Baldo Oliva, Philippe Clézardin, Omar E. Olarte, Pablo Loza‐Álvarez, Andrés Méndez‐Lucas, José C. Perales, Àngels Sierra	2013	33
13	Proximal Pathway Enrichment Analysis for Targeting Comorbid Diseases via Network Endopharmacology Pharmaceuticals ·Joaquim Aguirre‐Plans, Janet Piñero, Jörg Menche, Ferrán Sanz, Laura I. Furlong, Harald Schmidt, Baldo Oliva, Emre Güney	2018	33
14	GUILDify: a web server for phenotypic characterization of genes through biological data integration and network-based prioritization algorithms Bioinformatics ·Emre Güney, Javier Garcı́a-Garcı́a, Baldo Oliva	2014	32
15	Integrating Structure to Protein-Protein Interaction Networks That Drive Metastasis to Brain and Lung in Breast Cancer PLoS ONE ·H. Billur Engin, Emre Güney, Özlem Keskin, Baldo Oliva, Attila Gürsoy	2013	31
16	NOX5-induced uncoupling of endothelial NO synthase is a causal mechanism and theragnostic target of an age-related hypertension endotype PLoS Biology ·Mahmoud H. Elbatreek, Sepideh Sadegh, Elisa Anastasi, Emre Güney, Cristian Nogales, Tim Kacprowski, Ahmed Hassan, Andreas Teubner, Po‐Hsun Huang, Chien‐Yi Hsu, Paul Schiffers, G. Janßen, Pamela W. M. Kleikers, Anil Wipat, Jan Baumbach, Jo G. R. De Mey, Harald Schmidt	2020	30
17	Genetic and functional characterization of disease associations explains comorbidity Scientific Reports ·Carlota Rubio-Pérez, Emre Güney, Daniel Aguilar, Janet Piñero, Javier Garcı́a-Garcı́a, Barbara Iadarola, Ferrán Sanz, Narcís Fernández‐Fuentes, Laura I. Furlong, Baldo Oliva	2017	27
18	FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies Oncotarget ·Antonio Martínez-Aranda, Vanessa Hernández, Emre Güney, Laia Muixí, Ruben Foj, Núria Baixeras, Daniel Cuadras, Vı́ctor Moreno, Ander Urruticoechea, Miguel Ángel Cobos Gil, Baldo Oliva, Ferran Moreno, Eva González‐Suárez, Noemí Vidal, Xavier Andreu, Miguel Ángel Seguí, R. Ballester, Eva Castellà, Àngels Sierra	2015	27
19	iFrag: A Protein–Protein Interface Prediction Server Based on Sequence Fragments Journal of Molecular Biology ·Javier Garcı́a-Garcı́a, Victòria Valls-Comamala, Emre Güney, David Andreu, Francisco J. Muñoz, Narcís Fernández‐Fuentes, Baldo Oliva	2016	26
20	REPRODUCIBLE DRUG REPURPOSING: WHEN SIMILARITY DOES NOT SUFFICE PubMed ·Emre Güney	2016	23

About Emre Güney

Emre Güney is a scholar working on Molecular Biology, Computational Theory and Mathematics, Genetics, Pharmacology and Cognitive Neuroscience, having authored 43 papers that have together received 2.3k indexed citations. Recurring topics across this work include Bioinformatics and Genomic Networks (20 papers), Computational Drug Discovery Methods (17 papers), Machine Learning in Bioinformatics (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Autism Spectrum Disorder Research (4 papers), Genetics and Neurodevelopmental Disorders (4 papers), Protein Structure and Dynamics (3 papers) and Genetic Associations and Epidemiology (3 papers). The work is most often cited by research in Health Informatics (108 citations), Computational Theory and Mathematics (552 citations), Molecular Biology (1.4k citations), Biological Psychiatry (47 citations) and Pharmacology (121 citations). Emre Güney has collaborated with scholars based in Spain, United States and Netherlands. Frequent co-authors include Baldo Oliva, Jörg Menche, Albert-Ĺaszló Barabási, Marc Vidal, Harald Schmidt, Manuela G. López, Ahmed Hassan, Özlem Keskin, Attila Gürsoy and Nurcan Tunçbağ. Their work appears in journals such as Journal of Molecular Biology, BMC Bioinformatics, PLoS ONE, Scientific Reports and Drug Discovery Today.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact